Efficacy, Safety and Dose Selection of AZD3759 in Patients with Untreated <i>EGFR</i>-Mutated Non-Small-Cell Lung Cancer and Central Nervous System Metastases in a Phase 2, Multi-Center, Umbrella Trial (CTONG1702)
crossref（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要